Axon Kft.
- Address
- lock Available on a paid plan
Axon Kft. - Vasomotor Symptoms and Breast Cancer Research
Axon Kft. is a clinical research center specializing in women's health conditions related to breast cancer treatment. The center focuses on investigating novel therapeutic interventions for vasomotor symptoms (VMS), commonly known as hot flashes, which significantly impact quality of life in women undergoing hormonal therapies for breast cancer.
- Treatment of moderate to severe vasomotor symptoms in breast cancer patients receiving adjuvant endocrine therapy
- Evaluation of targeted pharmacological interventions including fezolinetant and elinzanetant for VMS management
- Clinical research in hormone receptor-positive breast cancer populations, including women at high risk for developing the disease
The center's research portfolio demonstrates expertise in conducting comparative efficacy studies evaluating emerging treatments against placebo in stage 0-3 hormone receptor-positive (HR+) breast cancer patients. Through systematic evaluation of both frequency and severity of vasomotor symptoms, Axon Kft. contributes to advancing therapeutic options for managing treatment-related side effects that affect breast cancer survivors and patients undergoing active hormonal therapy.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Chemo Research S.L.1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Chemo Research S.L.3trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 332 other sites in Hungary
Therapeutic Area Benchmark — Hungary
Select a therapeutic area to compare against other sites in Hungary.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Hungary
Market Share
Country: Hungary
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Axon Kft.
lock Showing 1 of 6 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A multicentre, single arm trial on contraceptive efficacy, safety and tolerability of LVDS (Levonorgestrel Vaginal Delivery System) during 13 cycles. | Chemo Research S.L. | Phase III | Not Recruiting | Jul 2023 | Aug 2025 |
IMP list
lock Showing 1 of 6 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Levonorgestrel | 2 | Unknown | 2023-07-12 | 2023-07-12 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.